| 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 商砼(元) | 189,161,550.09 | 348,586,589.02 | 148,383,400.97 |
| 生物医药(元) | 981,727,231.03 | 1,726,774,797.92 | 908,392,358.87 |
| 养老健康(元) | - | - | 54,040,452.66 |
| 养老医疗(元) | 69,021,036.29 | 130,122,501.30 | - |
| 其他(元) | 33,434,677.96 | 71,119,457.51 | 31,635,216.52 |
| 营业成本(元) | |||
| 商砼(元) | 149,114,805.44 | 259,488,801.49 | 114,141,506.98 |
| 生物医药(元) | 272,075,325.07 | 510,129,283.94 | 240,536,241.14 |
| 养老健康(元) | - | - | 65,897,060.54 |
| 养老医疗(元) | 75,527,674.57 | 147,331,676.80 | - |
| 其他(元) | 16,558,963.06 | 40,795,804.63 | 17,741,979.59 |
| 毛利(元) | |||
| 商砼(元) | 40,046,744.65 | 89,097,787.53 | 34,241,893.99 |
| 生物医药(元) | 709,651,905.96 | 1,216,645,513.98 | 667,856,117.73 |
| 养老健康(元) | - | - | -11,856,607.88 |
| 养老医疗(元) | -6,506,638.28 | -17,209,175.50 | - |
| 其他(元) | 16,875,714.90 | 30,323,652.88 | 13,893,236.93 |
| 毛利率(%) | |||
| 商砼(%) | 21.17 | 25.56 | 23.08 |
| 生物医药(%) | 72.29 | 70.46 | 73.52 |
| 养老健康(%) | - | - | -21.94 |
| 养老医疗(%) | -9.43 | -13.23 | - |
| 其他(%) | 50.47 | 42.64 | 43.92 |
| 收入构成(%) | |||
| 商砼(%) | 14.86 | 15.31 | 12.99 |
| 生物医药(%) | 77.10 | 75.85 | 79.51 |
| 养老健康(%) | - | - | 4.73 |
| 养老医疗(%) | 5.42 | 5.72 | - |
| 其他(%) | 2.63 | 3.12 | 2.77 |
| 毛利构成(%) | |||
| 商砼(%) | 5.27 | 6.76 | 4.86 |
| 生物医药(%) | 93.37 | 92.25 | 94.85 |
| 养老健康(%) | - | - | -1.68 |
| 养老医疗(%) | -0.86 | -1.30 | - |
| 其他(%) | 2.22 | 2.30 | 1.97 |